Subtitles section Play video
-
Mm.
-
The arrival of J and J's vaccine is another sign.
-
It's going to be a glorious spring.
-
Think back a year ago and March was miserable as people realized the coronavirus pandemic was here to stay within days.
-
If you remember, Tom Hanks said, he was sick.
-
The NBA canceled its season, and the S and P 500 plunged by nearly a third.
-
It's been awhile, but this march will see this gloom finally start to lift as lots of people get vaccinated.
-
A.
-
J and J's vaccine is the third authorized the United States, and it has some advantages.
-
Unlike those made by Pfizer and Moderna, it's easy to store and ship, and it only requires one dose instead of to.
-
What really matters, though, is simply getting more shots into more arms.
-
So far, just over 50 million Americans are about 15% of total population has received at least one vaccine.
-
That number could double in March.
-
That's because fighters more than doubling capacity to 15 million doses a week, and Modern is raising production to 40 million months.
-
The addition of J and J adds another 20 million this month and 100 million by the end of Jim.
-
In short, vaccine production is accelerating fast, and that will eventually translate into fewer people getting sick and dying and less transmission of the disease.
-
That spring may be beautiful, but I'll probably be just as fitting for drugmaker's profit.
-
JJ's vaccine is priced at a fraction of the offerings from Madura Advisor, about $10 a shot, and more vaccines will probably be approved soon.
-
Sure, it will take a while to Rolla vaccines worldwide, but every new approval and production increase is a sign of a beautiful spring.
